E Selectin News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Michael Andreeff, MD, PhD, discusses the rationale for investigating uproleselan plus venetoclax and azacitidine in patients with acute myeloid leukemia.

United statesMichael andreeffMary haasDepartment of leukemiaDepartment of hematologyDivision of cancer medicineUniversity of texas md anderson cancer centerMary haas chairBone marrow aspiration clinicMolecular hematologyCancer medicineFlow cytometryCellular imaging facilityCancer centerYin yangHematologic oncology